The economic burden of Clostridium difficile
- 1 March 2012
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 18 (3) , 282-289
- https://doi.org/10.1111/j.1469-0691.2011.03571.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Economic value of norovirus outbreak control measures in healthcare settingsClinical Microbiology & Infection, 2011
- Economic Impact of Acinetobacter baumannii Infection in the Intensive Care UnitInfection Control & Hospital Epidemiology, 2010
- Multicenter Study of Surveillance for Hospital-Onset Clostridium difficile Infection by the Use of ICD-9-CM Diagnosis CodesInfection Control & Hospital Epidemiology, 2010
- Will financial incentives and penalties improve hospital care?BMJ, 2010
- Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital CohortInfection Control & Hospital Epidemiology, 2010
- Cost-effectiveness of Implementing Low-Tidal Volume Ventilation in Patients With Acute Lung InjuryChest, 2009
- Clinical Risk Factors for SevereClostridium difficile–associated DiseaseEmerging Infectious Diseases, 2009
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Impact of Emergency Colectomy on Survival of Patients With Fulminant Clostridium difficile Colitis During an Epidemic Caused by a Hypervirulent StrainAnnals of Surgery, 2007
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989